Correlation Between Structure Therapeutics and Enliven Therapeutics
Can any of the company-specific risk be diversified away by investing in both Structure Therapeutics and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Structure Therapeutics and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Structure Therapeutics American and Enliven Therapeutics, you can compare the effects of market volatilities on Structure Therapeutics and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Structure Therapeutics with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Structure Therapeutics and Enliven Therapeutics.
Diversification Opportunities for Structure Therapeutics and Enliven Therapeutics
-0.04 | Correlation Coefficient |
Good diversification
The 3 months correlation between Structure and Enliven is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Structure Therapeutics America and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and Structure Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Structure Therapeutics American are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of Structure Therapeutics i.e., Structure Therapeutics and Enliven Therapeutics go up and down completely randomly.
Pair Corralation between Structure Therapeutics and Enliven Therapeutics
Given the investment horizon of 90 days Structure Therapeutics American is expected to under-perform the Enliven Therapeutics. In addition to that, Structure Therapeutics is 1.61 times more volatile than Enliven Therapeutics. It trades about -0.23 of its total potential returns per unit of risk. Enliven Therapeutics is currently generating about -0.22 per unit of volatility. If you would invest 2,897 in Enliven Therapeutics on August 24, 2024 and sell it today you would lose (356.00) from holding Enliven Therapeutics or give up 12.29% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Structure Therapeutics America vs. Enliven Therapeutics
Performance |
Timeline |
Structure Therapeutics |
Enliven Therapeutics |
Structure Therapeutics and Enliven Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Structure Therapeutics and Enliven Therapeutics
The main advantage of trading using opposite Structure Therapeutics and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Structure Therapeutics position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
Enliven Therapeutics vs. Pmv Pharmaceuticals | Enliven Therapeutics vs. Cullinan Oncology LLC | Enliven Therapeutics vs. Immuneering Corp | Enliven Therapeutics vs. Aerovate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Stocks Directory Find actively traded stocks across global markets | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |